Naltrexone And Bupropion
A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects
Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 1496
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| NB32 | 290 participants | 84 participants | 55 participants | n/r | n/r |
| Placebo | 34 participants | 10 participants | 18 participants | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.